CLOs on the Move


 
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market. Based in Los Angeles, MedMen employs over 1,100 team members across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.medmen.com
  • 8441 Warner Drive
    Culver City, CA USA 90232
  • Phone: 800.952.5210

Executives

Name Title Contact Details
Eduard Linetskiy
VP, Head of Compliance Profile
Lisa Sergi Trager
General Counsel Profile

Similar Companies

Comprehensive Pharmacy Services

Founded nearly 50 years ago and employing over 2,500 clinical, regulatory, and operational pharmacy professionals, Comprehensive Pharmacy Services is the nation`s oldest and largest provider of pharmacy support services to more than 700 hospitals and healthcare facilities across the United States and Puerto Rico. CPS helps hospital pharmacists tackle complex problems such as medication reconciliation, hyper-inflated drug costs, standardization, centralized distribution, regulatory & compliance, and 340B programs leading to increased quality, reduced admissions and lower costs. Services provided by CPS include pharmacy management, pharmacy consulting, specialized pharmacy services, telepharmacy, 340B program compliance assurance, ambulatory & retail pharmacy services, medication related transition of care, and pharmacy analytics.

Morning View Care Ctr

Morning View Care Ctr is a Centerburg, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cherry Health

Cherry Health is an independent, non-profit Federally Qualified Health Center (FQHC) with a primary focus of providing high quality health services to those who have little or no access to health care, regardless of income or insurance status. Services provided by Cherry Health include primary care, women`s health, pediatrics, dental, vision, behavioral health, mental health, correctional health, five school based health centers and employee assistance for employers. Cherry Health provides services to all individuals, regardless of their ability to pay. A sliding fee payment scale based on income and family size is available to those without insurance. Medicaid and Healthy Michigan are accepted, as are many other insurances. Established in 1988, Cherry Health is the largest FQHC in the state of Michigan serving Barry, Eaton, Kent, Montcalm and Wayne counties at more than 20 locations, 14 of which are primary care Federally Qualified Health Center sites, Cherry Health employs over 800 employees and a network of over 60 physicians and mid-level providers specializing in primary care/family medicine, pediatrics, internal medicine, obstetrics/gynecology, optometry and psychiatry. Additionally, Cherry Health runs a school linked program active in 70 public schools offering both vision and dental care.

University of North Carolina, School of Medicine

Our mission is to improve the health and wellbeing of North Carolinians and others whom we serve. We accomplish this by providing leadership and excellence in the interrelated areas of patient care, education, and research. We strive to promote faculty, staff and learner development in a diverse, respectful environment where our colleagues demonstrate professionalism, enhance learning, and create personal and professional sustainability. We optimize our partnership with the UNC Health Care System through close collaboration and a commitment to service.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.